Mentalization Orientated Psychoeducation Group for Adult ADHD (MOPAD) (MOPAD)
A Feasibility Study on Mentalization Orientated Psychoeducation Group for Adults With ADHD
Adults with Attention Deficit Hyperactivity Disorder (ADHD)-a neurodevelopmental condition affecting focus, impulse control, and activity levels-often face poor quality of life, emotion management difficulties, and interpersonal challenges. While medication helps core symptoms, it is not always tolerated or fully effective for emotional dysregulation. The National Institute for Health and Care Excellence (NICE) recommends psychological therapies as secondary options, but lacks sufficient evidence to endorse a specific intervention.
The MOPAD study tests whether an introductory Mentalization-Based Treatment (iMBT)-a psychological therapy helping people understand their own and others' mental states-can be delivered in a group format. MBT successfully improves mood and relationship issues in other conditions, offering potential non-drug benefits for adults with ADHD.
This non-randomised interventional feasibility study will recruit 16 adults with diagnosed ADHD. Participants will undertake a 12-week intervention of weekly 100-105 minute group iMBT sessions. Before and after the treatment, participants will complete standardized questionnaires assessing ADHD symptoms, quality of life, emotion regulation, impulsivity, and mentalizing capacity (e.g., ASRS v1.1, CAARS-2, AAQoL, DERS-18, UPPS, MENT-S, RFQ-8), alongside post-study qualitative interviews to share their experiences.
Eligible participants are adults with ADHD recruited from NHS clinical sites. Primary goals are evaluating recruitment (target: 11 participants), retention (target: 70%), safety, therapy fidelity, and patient acceptability. Secondary goals include evaluating clinician feedback and gathering resource data to calculate sample size requirements for a future full-scale trial.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Tayeem Pathan, MBBS MSC
- Numero di telefono: 0044-01483448020
- Email: tayeem.pathan@sabp.nhs.uk
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
-
• A minimum age of 18 - 65 years at time of consent
- Able to provide written consent with an Informed Consent Form signed by the participant
- Have ADHD as principal diagnosis using following diagnostic instruments. DIVA or ACE under an NHS Neurodevelopmental Service completed within the last 24 months.
- Proficient in spoken English.
Exclusion Criteria:
-
• Comorbidities of antisocial PD, autistic spectrum disorder, schizophrenia spectrum disorder, substance abuse disorder as principal or burdensome diagnosis, at the discretion of the PI.
- On a titrating dose of ADHD or other Psychotropic medication.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: Introductory Mentalization based group therapy
Adults with a Diagnosis of ADHD in last two years from a NHS Neurodevelopmental service. |
A psychological therapy helping people understand their own and others' mental state. 12 weeks group intervention. Each session will last 100-105 minutes including 10-15 minutes break. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
This study will examine the feasibility of delivering 12 weekly sessions (90minutes/session plus 10/15 min break in between) of iMBT in a group format to adults with ADHD.
Lasso di tempo: 20 months
|
Recruitment rate : The percentage of participants recruited in the study. It will be considered feasible if 11 out of 16 patients were recruited for the intervention. |
20 months
|
|
This study will examine the feasibility of delivering 12 weekly sessions (90minutes/session plus 10/15 min break in between) of iMBT in a group format to adults with ADHD.
Lasso di tempo: 20 months
|
Attrition rate : The percentage of participants retained in the study. It will be considered feasible if 70% were retained by the end of intervention. |
20 months
|
|
The study also aims to compare pre and post iMBT group clinical outcome data.
Lasso di tempo: 20 months
|
ASRS V1.1 (Adult ADHD self-report scale) :
|
20 months
|
|
The study also aims to compare pre and post iMBT group clinical outcome data.
Lasso di tempo: 20 months
|
CAARS-2 (Conners Adult ADHD Rating scale)
|
20 months
|
|
The study also aims to compare pre and post iMBT group clinical outcome data.
Lasso di tempo: 20 months
|
AAQoL (Adult ADHD Quality of life)
|
20 months
|
|
The study also aims to compare pre and post iMBT group clinical outcome data.
Lasso di tempo: 20 months
|
DERS-18 (Difficulties in Emotion regulation 18)
|
20 months
|
|
The study also aims to compare pre and post iMBT group clinical outcome data.
Lasso di tempo: 20 months
|
UPPS (Impulsive behaviour scale)
|
20 months
|
|
The study also aims to compare pre and post iMBT group clinical outcome data.
Lasso di tempo: 20 months
|
MENT-S (The mentalization scale)
|
20 months
|
|
The study also aims to compare pre and post iMBT group clinical outcome data.
Lasso di tempo: 20 months
|
RFQ-8 (Reflective function Questionnaire)
|
20 months
|
|
The study also aims to compare pre and post iMBT group clinical outcome data.
Lasso di tempo: 20 months
|
Adverse events (AE) or serious AE during the trial. This will counted in numbers identified through a clear process outlined in protocol. |
20 months
|
|
The study also aims to compare pre and post iMBT group clinical outcome data.
Lasso di tempo: 20 months
|
Fidelity of delivery : Adherence will be measured through supervision of the sessions and report from supervisors. |
20 months
|
|
The study also aims to compare pre and post iMBT group clinical outcome data.
Lasso di tempo: 20 months
|
Acceptability of the intervention to participants: through interview of the participants. Will be reported as themes and quotes from participants. |
20 months
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Resource outcomes:
Lasso di tempo: 20 months
|
Time taken to recruit participants: Reported in days |
20 months
|
|
Resource outcomes:
Lasso di tempo: 20 months
|
Sample size calculation in number |
20 months
|
|
Resource outcomes:
Lasso di tempo: 20 months
|
Data collection success (percentage of participants completed the outcome measures) |
20 months
|
|
Resource outcomes:
Lasso di tempo: 20 months
|
Initial assessment of the financial resources required to scale the study: reported in number of professionals involved and how much on average they had to offer in hours/week from the onset of recruitment to completion of the trial. |
20 months
|
|
Exploratory endpoints/outcomes
Lasso di tempo: 20 months
|
Participants experience of the intervention |
20 months
|
|
Exploratory endpoints/outcomes
Lasso di tempo: 20 months
|
Facilitators' and Co-facilitators' experience of the intervention. |
20 months
|
Collaboratori e investigatori
Sponsor
Sponsor
Pubblicazioni e link utili
Pubblicazioni generali
- American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing. Badoud, D., Rüfenacht, E., Debbané, M., & Perroud, N. (2018). Mentalization-based treatment for adults with attention-deficit/hyperactivity disorder: a pilot study. Research in Psychotherapy: Psychopathology, Process and Outcome, 21(1). Barkley, R. A. (2015). Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment (4th ed.). Guilford Publications. Bateman, A., & Fonagy, P. (2010). Randomized Controlled Trial of Outpatient Mentalization-Based Treatment Versus Structured Clinical Management for Borderline Personality Disorder. Focus, 8(1), 55-65. Bateman, A., Fonagy, P., Campbell, C., Luyten, P., & Debbané, M. (Eds.). (2023). Cambridge Guide to Mentalization-Based Treatment (MBT). Cambridge University Press. Bora, E., & Pantelis, C. (2016). Meta-analysis of social cognition in attention-deficit/hyperactivity disorder (ADHD): Expectation of deficits relative to controls and comparison with autism spectrum disorder. Psychological Medicine, 46(4), 681-704. Brown, N. M., Flood, T. J., Sarocco, P., Atkins, M. S., & Khachatryan, M. (2017). Social Determinants of Health and ADHD Symptoms in Preschool-Age Children. Journal of Attention Disorders, 26(3), 447-455. Cortese, S., Cinzia, D. G., Chamberlain, S., Philipsen, A., Young, S., Bilbow, A., & Cipriani, A. (2022). Pharmacological and non-pharmacological interventions for adults with ADHD: Protocol for a systematic review and network meta-analysis. BMJ Open, 12(3). https://doi.org/10.1136/bmjopen-2021-058102 Faraone, S. V., Asherson, P., Banaschewski, T., Biederman, J., Buitelaar, J. K., Ramos-Quiroga, J. A., ... & Franke, B. (2015). Attention-deficit/hyperactivity disorder. Nature Reviews Disease Primers, 1(1), 1-23. Fayyad, J., De Graaf, R., Kessler, R., Alonso, J., Angermeyer, M., Demyttenaere, K., ... & Jin, R. (2007). Cross-national prevalence and
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- SABPNHS
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Consent not given
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .